| scholarly article | Q13442814 |
| P50 | author | Ilya G Glezerman | Q59277558 |
| P2093 | author name string | Kenar D Jhaveri | |
| Ann A Jakubowski | |||
| Carlos D Flombaum | |||
| Alison M Edwards | |||
| Esperanza B Papadopoulos | |||
| James W Young | |||
| Thomas H Watson | |||
| P2860 | cites work | VEGF inhibition and renal thrombotic microangiopathy | Q24632792 |
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects | Q33341855 | ||
| De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy | Q33346269 | ||
| Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma | Q33359551 | ||
| Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation | Q33367451 | ||
| Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group | Q33373889 | ||
| Thrombotic microangiopathy following bone marrow transplantation. | Q33490461 | ||
| Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Q34557258 | ||
| T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin | Q36447884 | ||
| Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies | Q39213308 | ||
| Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation | Q40171377 | ||
| Chronic kidney disease following non-myeloablative hematopoietic cell transplantation | Q40356087 | ||
| A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment | Q42097784 | ||
| Significant increase in end-stage renal disease after hematopoietic stem cell transplantation | Q43812950 | ||
| Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation | Q43850604 | ||
| Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey | Q44261213 | ||
| Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation | Q44720181 | ||
| The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation | Q46884470 | ||
| Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease | Q51032360 | ||
| Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression | Q67254005 | ||
| Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
| Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry | Q77941016 | ||
| Stem cell transplantation nephropathy: a report of six cases | Q80390069 | ||
| Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study | Q80487619 | ||
| P433 | issue | 7 | |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 976-984 | |
| P577 | publication date | 2010-02-12 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation | |
| P478 | volume | 16 |
| Q26992169 | A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury |
| Q34448474 | Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States |
| Q58553367 | Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT |
| Q33412325 | Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy. |
| Q58041555 | GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation |
| Q38077918 | Glomerular diseases seen with cancer and chemotherapy: a narrative review |
| Q90655574 | Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy |
| Q33424902 | Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy |
| Q58415027 | Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation |
| Q33633514 | Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants |
| Q95501406 | Mini-review of kidney disease following hematopoietic stem cell transplant |
| Q33432069 | New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy |
| Q33430697 | Post-bone marrow transplant thrombotic microangiopathy |
| Q33905299 | Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations |
| Q33407913 | Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy |
| Q40740775 | Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series |
| Q40281926 | Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies |
| Q92092550 | Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab |
| Q64063450 | Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management |
| Q35660739 | Who is fit for allogeneic transplantation? |
Search more.